Abstract:Colorectal cancer (CRC) is one of the most common malignancies worldwide. The 5‐year survival rate of patients diagnosed with the early stages of the disease is markedly higher than that of patients in the advanced stages. Therefore, identifying novel biomarkers and drug targets for CRC is critical for clinical practice. Zinc finger protein 169 (ZNF169) is a crucial transcription factor, and its role in CRC remains to be explored. The present study aimed to investigate the clinical relevance, function and underlying mechanisms of ZNF169 in CRC growth and proliferation. The Cancer Genome Atlas (TCGA) database was utilized to analyze the clinical relevance of ZNF169 in patients with CRC. Immunohistochemical staining was performed on tissue samples from patients with CRC to detect the expression of ZNF169. The HCT‐116, HT‐29 and RKO cell lines were employed for in vitro experiments. The overexpression and knockdown of ZNF169 were achieved by transfecting the cells with lentivirus and small interfering RNAs, respectively. Cell Counting Kit‐8, colony formation and EdU staining assays were applied to investigate the function of ZNF169 in CRC cells. Dual luciferase activity and chromatin immunoprecipitation (ChIP)‐quantitative PCR (qPCR) assays were performed to identify the regulatory effects of ZNF169 on the ankyrin repeat and zinc‐finger domain‐containing 1 (ANKZF1; also known as ZNF744) gene. Reverse transcription‐quantitative PCR and western blot analysis were performed to measure mRNA and protein expression, respectively. The analysis of TCGA data revealed a positive correlation between ZNF169 and ANKZF1, with the overexpression of ANKZF1 being associated with a poor prognosis of patients with CRC. The experimental results demonstrated that ZNF169 was expression upregulated in CRC tissue compared with that in normal colon tissue. Gain‐of‐function and loss‐of‐function experiments revealed that ZNF169 enhanced the intensity of EdU staining, promoting the growth and proliferation of CRC cells. Furthermore, the overexpression of ZNF169 potentiated the transcriptional activity of the ANKZF1 gene, while the knockdown of ZNF169 produced the opposite results. ChIP‐qPCR confirmed the interaction between ZNF169 and the promoter sequence of ANKZF1. Rescue experiments revealed that ZNF169 accelerated CRC cell growth and proliferation through the upregulation of ANKZF1. Furthermore, there was a positive correlation identified between ZNF169 and ANKZF1, and upregulation of ANKZF1 expression was associated with the poor prognosis of patients with CRC. On the whole, the present study demonstrates that ZNF169 contributes to CRC malignancy by potentiating the expression of ANKZF1. Thus, the regulation of ZNF169 and/or ANKZF1 expression may represent a viable strategy for the treatment patients with CRC with a high expression of ZNF169.

Zinc finger protein 671 has a cancer-inhibiting function in colorectal carcinoma via the deactivation of Notch signaling

Zic1 Is Downregulated Through Promoter Hypermethylation, And Functions As A Tumor Suppressor Gene In Colorectal Cancer

Downregulation of ZNF365 by Methylation Predicts Poor Prognosis in Patients with Colorectal Cancer by Decreasing Phospho-P53 (ser15) Expression

Overexpression of ZNF169 promotes the growth and proliferation of colorectal cancer cells via the upregulation of ANKZF1

Zinc-finger Protein 545 is Inactivated Due to Promoter Methylation and Functions As a Tumor Suppressor Through the Wnt/β-catenin, PI3K/AKT and MAPK/ERK Signaling Pathways in Colorectal Cancer.

Methylation of ZNF331 is an Independent Prognostic Marker of Colorectal Cancer and Promotes Colorectal Cancer Growth

Role of ZIC1 Methylation in Hepatocellular Carcinoma and Its Clinical Significance

Inhibition of zinc finger protein 367 exerts a tumor suppressive role in colorectal cancer by affecting the activation of oncogenic YAP1 signaling

ZNF671 Inhibits the Proliferation and Metastasis of NSCLC via the Wnt/β-Catenin Pathway

Zinc finger protein 180 induces an apoptotic phenotype by activating METTL14 transcriptional activity in colorectal cancer

Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer

Zinc finger protein 263 promotes colorectal cancer cell progression by activating STAT3 and enhancing chemoradiotherapy resistance

Zinc Finger Protein 278, a Potential Oncogene in Human Colorectal Cancer.

KRAB Zinc-Finger Protein 382 Regulates Epithelial-Mesenchymal Transition and Functions As a Tumor Suppressor, but is Silenced by CpG Methylation in Gastric Cancer

Multilevel Regulation of Wnt Signaling by Zic2 in Colon Cancer Due to Mutation of Β-Catenin

ZNF331 Represses the Proliferation of Head and Neck Squamous Cell Carcinoma via Co‐Repressor TRIM28

The transcription factor ZNF248 promotes colorectal cancer metastasis by binding to ZEB1

ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer

ZNF516 suppresses stem cell-like characteristics by regulating the transcription of Sox2 in colorectal cancer.

ZNF677 Suppresses Renal Cell Carcinoma Progression Through N6‐methyladenosine and Transcriptional Repression of CDKN3

ZNF471 Interacts with BANP to Reduce Tumour Malignancy by Inactivating PI3K/AKT/mTOR Signalling but is Frequently Silenced by Aberrant Promoter Methylation in Renal Cell Carcinoma.